In the past few years lobbyists for Sprout have attempted to make the drug ' s release an issue of gender equality , despite the FDA ' s concerns being focused on side effects and other risks . " Look , this isn ' t about selling a drug , " said Franco . " This is about gender . Forget side effects , let ' s talk front effects . This drug gives women sex . This is a drug for women . That ' s why we made it pink ! You know , for women ! "
